Verbatim response from Perplexity
The best non-h hormonal treatment for hot flashes is Veozah (fezolinetant), the first FDA-approved medication specifically designed to treat moderate-to-severe hot flashes without using hormones, offering a targeted mechanism that blocks the neurokinin 3 receptor to regulate body temperature [11].
If Veozah is not accessible or suitable, low-dose paroxetine (brand name Brisdelle) is the only other FDA-approved non-hormonal medication for this purpose, though it typically provides a more modest reduction in symptoms (10–25% fewer hot flashes) compared to Veozah [5][9][14].
Key Comparison of Top Non-Hormonal Options
| Treatment | Status | Efficacy & Notes | Best For |
|---|---|---|---|
| Veozah (fezolinetant) | FDA-approved (2023) | Targets the brain's temperature control directly; considered the most effective non-hormonal prescription option [11][14]. | Moderate-to-severe hot flashes; women seeking the newest, most targeted therapy. |
| Brisdelle (paroxetine) | FDA-approved | Low-dose SSRI; reduces frequency by 10–25% and may help with sleep/mood [5][9][14]. | Those who need an approved option but may have mild-to-moderate symptoms or concurrent mood issues. |
| Gabapentin | Off-label | Consistent benefit in RCTs; higher doses (e.g., 900mg/day) can be effective but cause drowsiness/dizziness [6][13][14]. | Women who cannot take antidepressants or prefer an anticonvulsant option. |
| Venlafaxine (Effexor) | Off-label | Reduces hot flashes by 19–60%; an SNRI often well-tolerated [7][10]. | Women who also need treatment for anxiety or depression. |
Important Considerations
- Severity Matters: For mild hot flashes, lifestyle modifications are often the most practical first step, including using fans, wearing loose-fitting clothing, avoiding alcohol/spicy foods, and lowering room temperature [2][15].
- Breast Cancer History: For women on breast cancer treatment where hormones are contraindicated, gabapentin, venlafaxine, and escitalopram are frequently recommended effective alternatives [2][13].
- Newer Options: In addition to Veozah, a stellate ganglion blockade (nerve block) is emerging as a potential option for moderate-to-severe cases, though it is less common than medication [11].
Veozah is generally considered the superior choice for efficacy among non-hormonal drugs, but Brisdelle remains the standard alternative if Veozah is unavailable or if cost/access barriers exist.